Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 8c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of ($0.02), $0.08 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $7 million versus the consensus estimate of $6.26 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance